CASI Pharmaceuticals Inc Banner Image

CASI Pharmaceuticals Inc

  • Ticker CASI
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
CASI Pharmaceuticals Inc Logo Image
  • 51-200 Employees
  • Based in Rockville, Maryland
CASI Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, develops therapeutics to treat cancer and other diseases primarily in the United States and China. The company’s lead drug candidate includes ENMD-2076, an Aurora A and angiogenic kinase inhibitor for the treatment of cancer, which has completed Phase I studies in patients with advanced solid tumors, multiple myelomaMore, and leukemia, as well as it is completing data for a multi-center Phase II study in patients with platinum resistant ovarian cancer.
4.8 / 5.0 (131)

CASI Pharmaceuticals Inc reports have an aggregate usefulness score of 4.8 based on 131 reviews.

CASI Pharmaceuticals Inc

Most Recent Annual Report

CASI Pharmaceuticals Inc
MOST RECENT 2022 Annual Report
Add Annual Report To Cart

Older/Archived Annual Reports

CASI Pharmaceuticals Inc Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!